Advancing Safe and Sustainable by Design Practices in Pharmaceutical Manufacturing: The PHARMECO Project
ChemSusChem · 24.11.2025 · 18 (22)
DOI: 10.1002/cssc.202501218 ↗Kurz gefasst
Editorial in der Zeitschrift ChemSusChem, online erschienen am 10.10.2025. Verfasst von Sándor B Ötvös und 23 weiteren Autor:innen. Beteiligte Einrichtung: Center for Continuous Flow Synthesis and Processing (CCFLOW), Research Center Pharmaceutical Engineering GmbH (RCPE), Inffeldgasse 13, A-8010, Graz, …. Hauptthemen laut MEDLINE: Drug Industry. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Innovative Health Initiative Joint Undertaking.
Abstract (Originalsprache)
PHARMECO, a European public‐private partnership launched in November 2024, aims to trigger transformation in pharmaceutical manufacturing by advancing more sustainable technologies and reducing the industry's environmental footprint, without compromising quality or patient safety. Bringing together major pharmaceutical and medtech companies, universities, research organizations, small and medium‐sized enterprises, and a government institute, PHARMECO is driving a six‐year, multidisciplinary effort co‐funded by the European Union, private members of the Innovative Health Initiative Joint Undertaking (IHI JU), and UK Research and Innovation (UKRI). The project focuses on intensifying production processes and developing harmonized methods for assessing sustainability. In this Guest Editorial, members of the project's Steering Committee outline PHARMECO's vision, structure, and key approaches, and discuss its expected impact and long‐term contributions to sustainable healthcare in Europe. The article also introduces a special collection highlighting ongoing work carried out within the PHARMECO project.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Continuous Flow Synthesis and Processing (CCFLOW), Research Center Pharmaceutical Engineering GmbH (RCPE), Inffeldgasse 13, A-8010, Graz, Austria.
- Institute of Chemistry, University of Graz, NAWI Graz, Heinrichstrasse 28, A-8010, Graz, Austria.
- Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340, Beerse, Belgium.
- Sanofi R&D Synthetics Platform, Process Engineering, 45 Chemin de Météline, 04200, Sisteron, France.
- RISE Research Institutes of Sweden, Sven Hultins plats 5, 412 58, Göteborg, Sweden.
- Sanofi, 82 Avenue Raspail, 94250, Gentilly, France.
ORCID-Profile: Sándor B Ötvös
Förderung
- Innovative Health Initiative Joint Undertaking
Zitieren
APA
Ötvös, S. B., Verstappen, B., Baillon, B., Kappe, C. O., Weigelt, D., Luu, D. N., Brutin, F., Welsh, H., Dewulf, J., Caous, J., Colberg, J., Boone, L., Finkbeiner, M., Müllenborn, M., Schipper, N., Petronis, S., Hawdon, S., Fernandes, S. M., Braje, W. M., …, & Costers, S. (2025). Advancing Safe and Sustainable by Design Practices in Pharmaceutical Manufacturing: The PHARMECO Project. ChemSusChem, 18(22). https://doi.org/10.1002/cssc.202501218
Vancouver
Ötvös SB, Verstappen B, Baillon B, Kappe CO, Weigelt D, Luu DN, et al. Advancing Safe and Sustainable by Design Practices in Pharmaceutical Manufacturing: The PHARMECO Project. ChemSusChem. 2025;18(22). doi:10.1002/cssc.202501218
BibTeX
@article{tvs2025,
author = {Ötvös, Sándor B and Verstappen, Bert and Baillon, Bruno and Kappe, C Oliver and Weigelt, Dirk and Luu, Duc-Nam and Brutin, Fabienne and Welsh, Hannah and Dewulf, Jo and Caous, Josefin and Colberg, Juan and Boone, Lieselot and Finkbeiner, Matthias and Müllenborn, Matthias and Schipper, Nicolaas and Petronis, Sarunas and Hawdon, Simon and Fernandes, Steve Marquis and Braje, Wilfried M and Mackintosh, William and De Soete, Wouter and Bayon, Yves and Schönau, Christian and Costers, Sarah},
title = {Advancing Safe and Sustainable by Design Practices in Pharmaceutical Manufacturing: The PHARMECO Project},
journal = {ChemSusChem},
year = {2025},
volume = {18},
number = {22},
doi = {10.1002/cssc.202501218}
}
EUVIMED